Loading...

Archive

    06 July 2022, Volume 37 Issue 7 Previous Issue    Next Issue

    For Selected: Toggle Thumbnails
    Interpretation of the ACR guideline of 2021 for the treatment of juvenile idiopathic arthritis
    ZHENG Shao-ling, HUANG Chun-lin, LI Tian-wang, et al
    2022, 37(7): 481-485.  DOI: 10.19538/j.ek2022070601
    Abstract ( )  
    March 2022,the American College of Rheumatology(ACR)published guidelines for the treatment of juvenile idiopathic joints(JIA),focusing on the treatment pathways for oligoarthritis,temporomandibular joint(TMJ)arthritis,and systemic JIA(with or without MAS).Recommendations regarding tapering and discontinuing treatment in inactive systemic JIA are also provided.The main point is that glucocorticoids should not be used for a long time in child patients,and should be used for the shortest possible duration and at the lowest effective dose.It is important that clinical decisions should be made by the treating clinician and patient/caregiver.It is recommended that biosynthetic DMARDs(bDMARDs)or combin use with conventional synthetic DMARDs(csDMARDs)in active disease should be carried out as early as possible. In the non-systemic JIA,there is no recommendation for the optimal choice of bDMARDs.TNFi is the most commonly used and methotrexate is the first choice in csDMARD. IL-1 or IL-6 inhibitors are the first choice for systemic JIA.Abatacept and TNFi can be used as replacement therapy if response is poor. Evidence for all recommendations is graded as low or very low in quality,which should be noted.
    Nutrition support for children with liver diseases
    LI Dong-dan, WU Jie
    2022, 37(7): 486-490.  DOI: 10.19538/j.ek2022070602
    Abstract ( )  
    Liver disease is a common group of gastrointestinal diseases in children,which has a significant impact on childrens nutritional status,growth and development.Malnutrition can lead to further progression of liver disease,and the susceptibility to infection,surgical complications and mortality increase significantly.Attention should be paid to the evaluation of nutritional status of children with liver disease,the nutritional needs and differences of children with liver disease should be identified,and optimal nutrition management strategies should be made in order to improve clinical outcomes of children with liver disease.
    Herpes virus infection and liver injury in children
    SHEN Jun, WANG Jian-she
    2022, 37(7): 490-493.  DOI: 10.19538/j.ek2022070603
    Abstract ( )  
    Herpes virus infection-related liver injury refers to the damage of liver tissue cells in children caused by direct herpes virus infection or immune response,presented with elevated serum aminotransferase,etc.The Objective of this paper was to discuss the mechanism,diagnosis,treatment and follow-up of liver injury caused by herpes virus infection.
    Difficulties and countermeasures in the diagnosis and treatment of autoimmune hepatitis in children
    FANG Feng
    2022, 37(7): 493-495.  DOI: 10.19538/j.ek2022070604
    Abstract ( )  
    The incidence of autoimmune hepatitis in children is lower than in adults,but the liver of children is more susceptible to damage caused by factors such as infections or drugs,making it more difficult to diagnose.The impact on growth and development needs to be considered during the period of long-term immunosuppressive therapy,and there is more uncertainty.This paper refers to the latest relevant guidelines,and through combination with clinical practice,it discusses the difficulties in the diagnosis and treatment of childrens AIH,and puts forward relevant suggestions.
    Diagnosis and differential diagnosis of drug-induced liver injury in children
    ZHU Shi-shu, DONG Yi
    2022, 37(7): 496-500.  DOI: 10.19538/j.ek2022070605
    Abstract ( )  
    At present,there is no objective and specific diagnostic method for drug-induced liver injury in children,which still needs to be confirmed by clear medication history,association between drugs and liver injury,positive test of reexposure to suspected drugs and liver pathology,especially excluding other liver diseases.It is urgent to develop new biomarkers with higher specificity and sensitivity.
    Hyperbilirubinemia in children
    SUN Mei, LI Jian
    2022, 37(7): 500-504.  DOI: 10.19538/j.ek2022070606
    Abstract ( )  
    Hyperbilirubinemia in children often presents with jaundice,which is a common symptom in children,especially in infants and young children.Jaundice can be caused by a variety of pathophysiological,anatomical,infectious and autoimmune diseases,as well as genetic metabolic factors and diseases.Different causes of jaundice have different severity,prognosis,timing for treatment and plan for treatment.It is essential for patients to be diagnosed earlier and receive individualized treetment.With the development of molecular detection technology,Next-generation sequencing technology allows us to quickly and effectively make molecular diagnosis of diseases that cannot be directly diagnosed through conventional blood tests or liver biopsies,and then precise treatment can be given.This article mainly introduces the common causes of hyperbilirubinemia in children and their diagnosis and treatment strategies.
    Perioperative management of liver transplantation in children
    XIE Xin-bao
    2022, 37(7): 504-508.  DOI: 10.19538/j.ek2022070607
    Abstract ( )  
    Liver transplantation(LT)has become the standard treatment for children with end-stage liver disease or fulminant liver disease in many parts of the world.With the development of medical science,pediatric liver transplantation is developing rapidly,and the indications and contraindications of transplantation are changing constantly.The perioperative management of liver transplantation,such as selection of children and operation timing,preoperative evaluation of donors and recipients,preoperative medication and nutritional management of recipients and prevention and treatment of postoperative complications,needs multidisciplinary participation.Detailed perioperative management is an important part to determine the prognosis of children.Children undergoing liver transplantation must receive comprehensive care during the perioperative period.
    Pediatric acute liver failure
    ZHAO Yu
    2022, 37(7): 508-511.  DOI: 10.19538/j.ek2022070608
    Abstract ( )  
    Pediatric acute liver failure(PALF)is a severe and rapidly progressive clinical syndrome,which could induce multiple organ failure and even death.Given the complex cause and varied clinical presentation of PALF,it is hard to diagnose.It would be better to confirm the etiology based on clinical examination and history;early multidisciplinary treatment and prompt control of complications should be performed to improve the prognosis.
    Clinical characteristics and visual prognosis factors of uveitis associated with juvenile idiopathic arthritis:an analysis of 42 cases
    CAO Yu-jin, FANG Wang, LIANG Fang-fang, et al
    2022, 37(7): 512-515.  DOI: 10.19538/j.ek2022070609
    Abstract ( )  
    Objective To analyze the clinical features of uveitis associated with juvenile idiopathic arthritis(JIA)and to explore the risk factors affecting its incidence and visual prognosis.Methods The clinical data of patients under 16 years of age with JIA-associated uveitis in the Department of Ophthalmology and Rheumatology in Shenzhen Childrens Hospital from November 2014 to March 2021 were collected and analyzed statistically.Results Totally 42 patients(71 eyes)with JIA-associated uveitis were collected,including 16 males(28 eyes)and 26 females(43 eyes).The male to female ratio equaled 1:1.625.The age of onset of uveitis ranged from 4 to 16 years,with an average age of(8.8±2.6)years.The follow-up time ranged from 2 months to 6.3 years,with a media follow-up time of 2.7(1.0,4.1)years.The acute disease course was in 5 eyes(7.0%),chronic course 66 eyes(93.0%)and recurrent course 11 eyes(15.5%).Anterior uveitis was found in 60 eyes (84.5%)and panuveits in 11 eyes(15.5%).There were 13 cases(31.0%)of unilateral uveitis,29 cases(69.0%)of bilateral uveitis.There were 35 cases of oligoarticular type(83.3%),6 cases of rheumatoid factor(RF)negative polyarticular type(14.3%)and 1 case of RF positive polyarticular type(2.4%).In the tested white blood cell(WBC)number,erythrocyte  sedimentation rate(ESR),C-reactive protein(CRP)and rheumatoid factor(RF),there was no significant difference between male and female(all P>0.05).There were 20 female and 7 male patients with antinuclear antibody(ANA)(+),and the difference was statistically significant(χ2=4.747.P<0.05).The following factors were related to poor visual prognosis:the onset age≤6 years old,the course of disease>4 years old,the best correlated visual acuity(BCVA)≤0.4 and the complications>2(all P<0.05).Conclusion Chronic JIA-associated uveitis is common,and it often occurs in both eyes.Anterior uveitis is the most common anatomical type.Posterior synechia is the most common ocular complication.Children with oligoarticular type JIA,ANA(+)and RF(-)JIA are more prone to uveitis.The prognosis of visual acuity is correlated with age of onset,duration of disease,initial diagnosis of BCVA and number of complications.
    Analysis of etiology and clinical features of 36 children with cirrhosis
    ZOU Biao , LIU Sheng-hui, HE Jia-yi, et al
    2022, 37(7): 516-522.  DOI: 10.19538/j.ek2022070610
    Abstract ( )  
    Objective To explore the etiology and clinical features of pediatric cirrhosis,to understand its prognosis,and to improve the levels of diagnosis and treatment of it.Methods The clinical data of 36 cases of childhood cirrhosis treated in Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology from October 2016 to December 2020 were studied.The clinical data included,gender,age,past history,etiology,clinical manifestations,complications,nutritional status at diagnosis,laboratory test results,genetic results,post-treatment follow-up.Compare the related indicators between the good prognosis group and the death group.Results Among the 36 patients with cirrhosis,18 were male and 18 were female with,the age was 51.7(5,84)months;13 cases had biliary atresia,6 were Wilson diseases,Carolis disease had 2 cases,progressive familial intrahepatic cholestasis(PFIC)2 cases;there were 7 patients with cryptogenic cirrhosis,one hereditary hemorrhagic telangiectasia(HHT),one case of Niemann-Pick disease,one case of congenital bile acid synthesis defect,case of hepatitis B cirrhosis,case of neonatal intrahepatic cholestasis(NICCD),and one case of Shwachman-Diamond syndrome(SDS).The main clinical features were splenomegaly in 18 cases(50%),skin jaundice in 16 cases(44.4%),fever in 10 cases(27.7%),abdominal distension in 10 cases(27.7%),gastrointestinal bleeding in 6 cases(16.6%)and vomiting in 4 cases(11.1%),etc.At the time of diagnosis of cirrhosis,the number of children with underweight and growth retardation was 8(22.2%)and 12(33.3%)respectively.Ultrasonography was performed in all 36 cases to diagnose cirrhosis,abdominal CT examination showed cirrhosis in 14 cases,and 15 patients were diagnosed through histopathology.The main complications included esophagogastric fundus varicose veins in 9 cases(26.4%),hypersplenia and/or cytopenia in 8 cases(23.5%),and ascites in 6 cases(16.6%),etc.Genetic tests were performed in 10 children,and pathogenic genes were detected in 6 cases,including NPC1,ABCB4,SADM4,ATP7B,SBDS and SLC25A13.All the children were treated according to etiology,and the symptomatic supportive treatment such as liver protection and antixanthosis was added.Among them,27(75%)were in good general condition,7(19.4%)died,8 had been treated with liver transplantation,and 2 were currently awaiting liver transplantation.There was no significant difference in alanine aminotransferase(ALT),aspartate aminotransferase(AST),γ -glutamyl transpeptidase(GGT),prothrombin time(PT),platelet or total bilirubin(TBIL)between the good prognosis group and the death group(P>0.05).There was statistically significant difference in age,albumin(ALB)and direct bilirubin(DBIL)at the time of diagnosis(P<0.05).Conclusion The etiology of cirrhosis in children is very different from that in adults. biliary atresia is the most common etiology;B-ultrasonography is the most common examination method for its diagnosis;malnutrition is easy to occur,so it is suggested to strengthen nutritional supplements;pediatric cirrhosis with younger age,lower albumin and higher direct bilirubin has poor prognosis and high mortality.
    Observation and summary of medium-and long-term efficacy of tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    YAO Hua, TANG Han-yun, WANG Wen-juan, et al
    2022, 37(7): 523-526.  DOI: 10.19538/j.ek2022070611
    Abstract ( )  
    Objective To summarize the dosing regimen of tocilizumab and to explore a feasible,practical and economical treatment for systemic juvenile idiopathic arthritis.Methods A retrospective study was carried out based on the data of children with systemic juvenile idiopathic arthritis treated with tocilizumab from March 2014 to March 2020 in the Department of Kidney and Immunology,Childrens Hospital of Soochow University.The administration intervals,drug efficacy,hormone reduction,and adverse reactions of tocilizumab were collected for analysis and summary.Results Among the 15 cases collected,the age of onset was(6.75±2.84),the average course of disease was(3.53±2.90)years and the course of tocilizumab treatment was(2.02±0.96)years.All 15 patients were treated with tocilizumab and gradually the interval of medication was extended from 2 weeks based on the condition of the disease.One of the patients had been discontinued tocilizumab after the interval was extended to 24 weeks,while the remaining 14 cases still used the drug and received examinations regularly in the clinic.Adverse reactions observed during the treatment included allergy,mild transaminase rise and gastrointestinal infection.Conclusion The clinical symptoms of the children are improved significantly after the administration of tocilizumab. The interval of administration of tocilizumab should be prolonged gradually based on disease condition until the drug is stopped.In addition,MAS should be paid more attention to during the treatment of tocilizumab.
    Clinical analysis of 17 patients with Takayasu arteritis in children
    TAN Ao-xue, TANG Xue-mei
    2022, 37(7): 527-531.  DOI: 10.19538/j.ek2022070612
    Abstract ( )  
    Objective To explore the clinical characteristics and treatment outcome of child patients with Takayasu arteritis in order to improve the understancling of it.Methods A retrospective review was performed on all patients visiting our hospital from 2003 to 2020 who met EULAR-PReS-PRINTO classification criteria for childhood Takayasu arteritis.The Paediatric Vasculitis Activity Score(PVAS),Indian Takayasu Arteritis Activity Score(ITAS)and Disease Extent Index-Takayasu(DEI.Tak)were used to assess disease activity.Results The onset age of seventeen subjects(5 male and 12 female)was from 1.3 to 14 years old.The diagnostic delay was from 18 days to 6 months.The most common clinical manifestations were hypertension(12 cases,70.6%),headache or dizziness(9 cases,52.9%),blood pressure discrepancy(7 cases 41.2%),fever(7 cases 41.2%),bruits(7 cases 41.2%),vomit(6 cases,35.3%)and arthralgia(6 cases,35.3%).The inflammatory indexes were increased ESR in 13 cases(84.6%),increased CRP in 11 cases(64.7%) and increased WBC in 11 cases(64.7%).The most common angiographic involvement type according to the Numano classification system was type Ⅴ seen in six patients(37.5%),followed by type Ⅳ in four patients(25.0%).The abdominal aorta(12 cases,70.6%)and left renal artery(10 cases 58.8%)were the most commonly involved vessels.The most common type of abnormality in our patients was thickening of vacular wall(42 cases,45.7%)followed by stenosis(27,29.3%).At the beginning of disease,a medium or strong correlation was found between PVAS and ITAS(rs=0.789;P<0.05)and between PVAS and DEI.TaK(rs=0.756;P<0.05).Glucocorticoids and immunosuppressants were most commonly used medicine.Four patients required surgical intervention for hypertension with poor control in which there were 3 cases of balloon dilatation. The follow-up lasted from half a year to 3 years,and eight cases were improved,four cases were lost to follow up,three cases got worse and two cases died.Conclusion For patients with unexplained hypertension and high expression of inflammatory markers we should be alert to the occurrence of Takayasu arteritis, and we shoul pay more attention to physical examination and strengthen the assessment of disease activity.
    Allan-Herndon-Dudley syndrome in 4 cases and literature review
    LU Fen, ZHANG Li, TANG Jian, et al
    2022, 37(7): 532-536.  DOI: 10.19538/j.ek2022070613
    Abstract ( )  
    One case of RAS gene-associated autoimmune lymphoproliferative disease and literature review
    TANG Wen-jing, ZHANG Yu, ZHANG Zhi-yong, et al
    2022, 37(7): 537-540.  DOI: 10.19538/j.ek2022070614
    Abstract ( )  
    Research progress in the treatment and prognosis of PCDH19 gene-associated epilepsy
    CHEN Yi, ZHANG Yue-hua
    2022, 37(7): 541-545.  DOI: 10.19538/j.ek2022070615
    Abstract ( )  
    Potential value of biological agents in the treatment of children with eosinophilic gastrointestinal diseases
    LI Jing, WU Jie, WANG Tian-you
    2022, 37(7): 546-549.  DOI: 10.19538/j.ek2022070616
    Abstract ( )  
    Research progress in the impact on the prognosis of RNF213 gene-associated moyamoya disease
    XU Jia-ning, WANG Hua
    2022, 37(7): 550-556.  DOI: 10.19538/j.ek2022070617
    Abstract ( )  
    One case report of tocilizumab in the treatment of systemic lupus erythematosus complicated with macrophage activation syndrome and acute respiratory distress syndrome
    LU Lin, LU Mei-ping
    2022, 37(7): 557-560.  DOI: 10.19538/j.ek2022070618
    Abstract ( )